It is Anti-malarial drug. Anti-malarial drugs are the medicines used to prevent and treat malaria. The malaria is the disease caused due to the parasite known as Plasmodium, belongs to the organism group Protozoa. The malaria disease occurred in the tropical, subtropical and temperate regions of the world. Around 3.3 Billion people as half of the worlds population are at a risk of contracting malaria. Every year near about 250 million malaria cases leads to the death of 1 million globally. The anti-malarial drugs are work in the treatment of malaria in individuals, prevention of infection in individuals and conventional intermittent treatment in the specific group in most prevalence endemic regions. Generally, malaria is treated by the single drug therapy as a first line therapy, and sometimes the combination drug therapy is for the second line of infection. Anti-malarial drugs are available in the market in the form of tablet, injectables, and capsules.
This report elaborates the market size, market characteristics, and market growth of the Drugs For Malaria industry, and breaks down according to the type, application, and consumption area of Drugs For Malaria. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Drugs For Malaria in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Drugs For Malaria market covered in Chapter 13:
Mylan Labs
Novartis
Sanofi Aventis
Ajanta Pharma
IPCA Laboratories
Cipla
GlaxoSmithKline
Guilin Pharmaceutical
Roche

In Chapter 6, on the basis of types, the Drugs For Malaria market from 2015 to 2025 is primarily split into:
Quinine
Chloroquine
Amodiaquine
Pyrimethamine
Sulfonamide
Others

In Chapter 7, on the basis of applications, the Drugs For Malaria market from 2015 to 2025 covers:
Treatment
Prevention
Resistance
Others

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025